期刊文献+

2002-2011年医院病原菌分布与耐药性分析 被引量:8

Distribution and drug resistance of pathogens causing nosocomial infections during 2002-2011
原文传递
导出
摘要 目的分析医院2002-2011年病原菌分布及耐药性,以指导临床抗菌药物合理使用。方法回顾性分析2002-2011年送检样本的病原菌分布及主要病原菌的耐药性;采用法国生物梅里埃公司VITEK-2全自动细菌分析仪及其配套鉴定卡进行菌株鉴定及药敏试验。结果 2002-2011年送检样本呈明显增多趋势,2002-2011年医院感染患者共分离出病原菌24 246株,革兰阴性菌占69.9%,前4位菌依次为肺炎克雷伯菌、大肠埃希菌、铜绿假单胞菌、鲍氏不动杆菌;革兰阳性菌占25.45%,前4位菌依次为金黄色葡萄球菌、表皮葡萄球菌、粪肠球菌、溶血葡萄球菌;真菌占4.65%,以白色假丝酵母菌为主;病原菌主要分离自呼吸道占39.41%~57.24%,其次是创面分泌物占14.51%~22.94%;肺炎克雷伯菌对碳青霉烯类的耐药率10年来一直较低,对头孢哌酮/舒巴坦虽呈上升趋势却不明显,但对氨基糖苷类和喹诺酮类抗菌药物耐药的菌株越来越多,金黄色葡萄球菌10年间未发现耐万古霉素菌株。结论医院病原菌以革兰阴性菌为主,其中主要是肺炎克雷伯菌,其对头孢哌酮/舒巴坦、碳青酶烯类抗菌药物在10年间变化不明显。 OBJECTIVE To analyze the distribution and drug resistance of pathogens that can cause nosocomial infection during 2002-2012,so as to guide the rational use of antibacterial agents.METHODS The distribution of the pathogens and drug resistance of main pathogens sent during 2002-2012were retrospectively analyzed;strain identification and antimicrobial susceptibility test was conducted by BioMerieux VITEK-2full-automatic bacterial analyzer and its associated identification cards.RESULTS The number of samples for test was increased obviously during 2002-2012;a total of 24,246strains of pathogens were isolated from infected patients during the ten years,gram-negative bacteria accounted for 69.9%,and the top four pathogens in order were Klebsiella pneumonia,Escherichia coli,PAE and ABA;gram-positive bacterium accounted for 25.45%,and the top four pathogens in order were Staphylococcus aureus,S.epidermidis,Enterococcus faecalis and S.haemolyticus;fungi accounted for 4.65%,and Candida albicans was the majority.A total of 39.41%-57.24% pathogens were isolated from respiratory tract,followed by secreta(14.51%-22.94%)from wound surface.The drug resistance of K. pneumoniaagainst carbapenems was still low in the ten years,and there were no clear indications of increase in terms of resistance against cefoperazone/sulbactam,while the strains which can resist aminoglycosides and quinolones kept increasing;there were no indications proved that S.aureus could resist vancomycin during the years.CONCLUSIONS The main pathogen detected in hospital is gram-negative bacteria,and K.pneumoniais the majority;its changes in resistance against cefoperazone/sulbactam and carbapenems have no clear indication.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2014年第9期2096-2098,共3页 Chinese Journal of Nosocomiology
基金 天津市卫生局科技基金资助项目(10KG104)
关键词 病原菌 监测 耐药 Pathogens Monitoring Drug resistance
  • 相关文献

参考文献5

  • 1Hernandez-Alles S, Benedi VJ, Martinez-Martinez L, et al. Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes[J]. Ant imicrob Agents Chem other, 1999,43(4) : 937.
  • 2Perez-Moreno MO, Carcilla M. Mechanisms of reduced sus- ceptibility to amoxycillin-clavulanic acid in Escherichia colis- train from the health region of Tortosa(Cafalonia,Spain)[J]. Clin Microbiol Infect, 2004,10(30) : 234.
  • 3Andel JN, Franklin MJ,Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicllin and ciprofloxacin[J]. Antimicrob Agents Chemother, 2004,44(7) : 1818.
  • 4Schneiders T, Amyes SG, Levy SB. Role of AcrR and RamA influoroquin ol one resistance in clinical Klcbsiella pneumoniae isolates from Singapore[J]. Antimicrob Agents Chemother, 2003,47(9) :2831.
  • 5Cattoir V, Nordmann P. Plasmid-mediat edquinolone resistance in gram-negative baeterial species: an update. Curr Med Chem, 2009,16 (8):[J] 1028-1046.

同被引文献90

  • 1宿庄,毕力夫,宿敏,张海蓉,樊雪强,张专才.呼和浩特市1998至2004年医院感染流行病学调查[J].中华预防医学杂志,2006,40(1):45-45. 被引量:2
  • 2杨平满,周建英.常见多重耐药菌的耐药机制及防治对策[J].中华医院感染学杂志,2006,16(12):1434-1437. 被引量:144
  • 3刘绍德,莫永生,莫惠平,陆德胜,潘秋荣,谭柳群,李智坚.常见病原菌耐药性及抗菌药物不合理应用分析[J].中华医院感染学杂志,2007,17(1):81-82. 被引量:48
  • 4Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment[J]. Med Mycol, 2007, 45(4): 321-346. doi:10.1080/13693780701218689.
  • 5Kabir MA, Hussain MA. Human fungal pathogen Candida albicans in the postgenomic era: an overview[J]. Expert Rev Anti Infect Ther, 2009, 7(1): 121-134. doi:10.1586/14787210.7.1.121.
  • 6Wilson D, Thewes S, Zakikhany K, et al. Identifying infection-associated genes of Candida albicans in the postgenomic era[J]. FEMS Yeast Res, 2009, 9(5): 688-700. doi:10.1111/j.1567-1364.2009.00524.x.
  • 7Sorgo AG, Heilmann CJ, Dekker HL, et al. Effects of fluconazole on the secretome, the wall proteome, and wall integrity of the clinical fungus Candida albicans [J]. Eukaryote Cell, 2011, 10(8): 1071-1081. doi:10.1128/EC.05011-11.
  • 8Higgins J, Pinjon E, Oltean HN, et al. Triclosan antagonizes fluconazole activity against Candida albicans [J]. J Dent Res, 2012, 91(1): 65-70. doi:10.1177/0022034511425046.
  • 9Alarco AM, Raymond M. The bZip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans [J]. J Bacteriol, 1999, 181(3): 700-708. doi:10.1016/j.gene.2006.08.010.
  • 10Ferrari S, Sanguinetti M, Torelli R, et al. Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata [J]. PLoS One, 2011, 6(3): 17589. doi:10.1371/journal.pone.0017589.

引证文献8

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部